FLT3 and acute myeloid leukemia: For instance, metabolomic analyses revealed that NPM1-mutated AML is characterized by high levels of free carnitine, whereas FLT3-ITD displays significant alterations in amino acid metabolism, particularly involving glutamic and aspartic acids, highlighting the key role of glutaminolysis and energy metabolism pathways in differentiating these subtypes [162].